NCT05685836View on ClinicalTrials.gov

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

RecruitingOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Neurofibromatosis 2

Interventions

DRUG

Bevacizumab Zirconium Zr-89

See Arm description.

Trial Locations (1)

2333ZA

RECRUITING

Leiden University Medical Center, Leiden

All Listed Sponsors

lead

Leiden University Medical Center

OTHER